# Improving Treatment of Inflammatory Bowel Diseases Through Better Understanding Infliximab Drug and Antibody Levels

> **NCT01787786** · — · WITHDRAWN · sponsor: **University of Western Ontario, Canada**

## Conditions studied

- Crohn's Disease
- Ulcerative Colitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01787786
- **Lead sponsor:** University of Western Ontario, Canada
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2017-03
- **Final completion:** 2017-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to align the study questions with a complementary trial
- **Last updated:** 2015-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01787786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01787786, "Improving Treatment of Inflammatory Bowel Diseases Through Better Understanding Infliximab Drug and Antibody Levels". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01787786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*